https://doi.org/10.1158/2326-6066.c.7311468.v1
H
Haoyun Zhuang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
55
Papers
3
Citations
1
h-index
0
i10-index
Haoyun Zhuang is an academic researcher from Xiamen University. The author has contributed to research in topics: Immunotherapy and Immune Responses & Monoclonal and Polyclonal Antibodies Research & CAR-T cell therapy research. The author has an h-index of 1, co-authored 47 publications.
ORCID: 0009-0006-5305-6739Papers by this author
worksData from Orchestrated Codelivery of Peptide Antigen and Adjuvant to Antigen-Presenting Cells by Using an Engineered Chimeric Peptide Enhances Antitumor T-Cell Immunity
2024 · 0 citations
Supplementary Fig. S23 from Orchestrated Codelivery of Peptide Antigen and Adjuvant to Antigen-Presenting Cells by Using an Engineered Chimeric Peptide Enhances Antitumor T-Cell Immunity
2024 · 0 citations
https://doi.org/10.1158/2326-6066.26145117
Supplementary Table S1 from Orchestrated Codelivery of Peptide Antigen and Adjuvant to Antigen-Presenting Cells by Using an Engineered Chimeric Peptide Enhances Antitumor T-Cell Immunity
2024 · 0 citations
https://doi.org/10.1158/2326-6066.26145084
Supplementary Fig. S8 from Orchestrated Codelivery of Peptide Antigen and Adjuvant to Antigen-Presenting Cells by Using an Engineered Chimeric Peptide Enhances Antitumor T-Cell Immunity
2024 · 0 citations
https://doi.org/10.1158/2326-6066.26145093
Supplementary Fig. S4 from Orchestrated Codelivery of Peptide Antigen and Adjuvant to Antigen-Presenting Cells by Using an Engineered Chimeric Peptide Enhances Antitumor T-Cell Immunity
2024 · 0 citations
https://doi.org/10.1158/2326-6066.26145108
Supplementary Fig. S19 from Orchestrated Codelivery of Peptide Antigen and Adjuvant to Antigen-Presenting Cells by Using an Engineered Chimeric Peptide Enhances Antitumor T-Cell Immunity
2024 · 0 citations
https://doi.org/10.1158/2326-6066.26145135
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat